title: Evaluation of expanded program on immunization during the first year of life in Abu Dhabi.
abstract: This study was intended to highlight the program of vaccination in the first year of life against the Expanded Program on Immunization (EPI)-target diseases and to determine the trend of these diseases in Abu Dhabi during 1984-1989. The data were collected from annual reports of Ministry of Health. This retrospective study pointed out to the following results: (1) The average vaccination coverage (percent) during the first year of life against EPI-Target diseases increased gradually during 1984, 1986, 1987, 1988, 1989. (2) The vaccination coverage (percent) during the first year of life using BCG and measles vaccines are increased significantly (p < 0.001) during 1985-1989 compared with 1984. (3) The vaccination coverage (percent) during the first year of life using OPV and DPT at the third dose are increased significantly (p < 0.05) during 1987-1989 compared with 1984. (4) The reported cases of measles and its incidence rate consequently decreased during 1988-1989 compared with 1987 and the differences are statistically significant (p < 0.001). The reported cases of diphtheria and its incidence rate show significant increase (p < 0.01) during 1988 compared with 1984. Other EPI target diseases do not show any statistically significant difference (p > 0.05) during 1985-1989 compared with 1984. Based on this study it can be concluded that with increase in average vaccination coverage (percent) from 58.5% in 1984 to 82.9% in 1989, the number of reported cases of EPI target diseases decreased.
authors.affiliation: Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Akef
authors.forename: M
authors.initials: M
authors.lastname: Radwan
authors.forename: A S
authors.initials: AS
authors.lastname: Hafez
mesh_terms: D003140:Communicable Disease Control / Q000706:statistics & numerical data*; D003141:Communicable Diseases / Q000453:epidemiology*; D003906:Developing Countries; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D004534:Egypt / Q000453:epidemiology; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data*; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008458:Measles Vaccine; D012189:Retrospective Studies
chemical_list: D015721:Diphtheria-Tetanus-Pertussis Vaccine; D008458:Measles Vaccine